This public procurement record has 6 releases in its history.

Award

20 Aug 2025 at 08:17

Award

11 Jul 2025 at 13:24

Award

11 Jul 2025 at 10:52

TenderUpdate

07 May 2025 at 11:50

Tender

07 May 2025 at 10:42

Planning

09 Apr 2025 at 12:44

Summary of the contracting process

The NHS England has successfully awarded a contract for the NHS National Framework for Transition products (Nilotinib and Ticagrelor), which was initiated under an open procedure. This framework, beginning on 1st September 2025, and running until 31st January 2027, involves the supply of pharmaceutical products across various UK regions, with the possibility of extension up to 24 months. With the contract award completed, the framework agreement features multiple suppliers, including Zydus Pharmaceuticals UK Ltd, Accord-UK Ltd, and AstraZeneca, among others, underlining strategic partnerships in the pharmaceutical industry. Key procurement dates include the contract signature on 4th August 2025 and full details can be accessed on the NHS England website or via the awarded contract notice link.

For businesses looking to grow, particularly those in the pharmaceutical sector, this framework presents a substantial opportunity to engage with NHS England, a major public authority in the UK. The contract value, weighted towards significant pharmaceutical development and distribution, offers ample room for both large corporations and SMEs to contribute, resulting in diverse economic benefits. Companies with robust supply chain capabilities and a focus on innovative health solutions will be well-positioned to succeed in future engagements and ensure adherence to NHS standards, fostering long-term partnerships with the NHS.

How relevant is this notice?

Notice Title

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

Notice Description

Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework. Additional Unsuccessful supplier not listed due to technical error: Torrent Pharma (UK) Ltd

Lot Information

Lot 1

Renewal: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Planning Information

NHS England is pleased to invite suppliers to contact us in relation to the upcoming tender for NHS National Framework for Transition products commencing 1st September 2025 (Ticagrelor and Nilotinib ) Please contact katie.noonan@nhs.net for further information and/or to register your interest.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04ff90
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/049985-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£29,042,000 £10M-£100M
Lots Value
£29,042,000 £10M-£100M
Awards Value
£22,097,000 £10M-£100M
Contracts Value
£22,097,000 £10M-£100M

Notice Dates

Publication Date
20 Aug 20251 years ago
Submission Deadline
9 Jun 2025Expired
Future Notice Date
30 Apr 2025Expired
Award Date
12 Jun 20251 years ago
Contract Period
1 Sep 2025 - 31 Jan 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active, Pending
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

NHS ENGLAND

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
12
Supplier Names

ASTRAZENECA UK LIMITED

Accord-UK Ltd

AstraZeneca

C. S. T. PHARMA LIMITED

DR REDDY'S LABORATORIES (UK) LIMITED

Dr.Reddy's Laboratories (UK) Limited

MSN Laboratories Europe Limited

NOVARTIS PHARMACEUTICALS UK LIMITED

Novartis Pharmaceuticals UK Ltd

ZENTIVA PHARMA UK LIMITED

Zentiva Pharma UK Ltd

Zydus Pharmaceuticals UK Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...